Conference Coverage

Neuropsychiatric Disorders in MS Are Common and Treatable


 

References

Bipolar affective disorder is twice as common among individuals with MS as it is in the general population. The disorder is characterized by grandiosity, elevated mood, irritability, and increased motor activity. No data are available about treating bipolar affective disorder in patients with MS, so neurologists must consult the psychiatric literature. “Patients respond well to mood-stabilizing medication such as lithium or valproic acid,” said Dr. Feinstein. “If your patients are psychotic, occasionally you have to introduce an antipsychotic agent as well.”

Between 9% and 13% of patients with MS have euphoria, an exaggerated feeling of mental and physical well-being. People with MS and euphoria tend to have significant brain atrophy and heavy lesion load, and no treatments for euphoria exist. Treating the disorder might be undesirable anyway, although it adds to the burden on the patient’s caregiver, said Dr. Feinstein.

Erik Greb

Pages

Recommended Reading

Two-Year Data Support the Sustained Efficacy of Pegylated Interferon Beta-1a
MDedge Neurology
New Glatiramer Acetate Dosing Regimen for MS May Be Safer
MDedge Neurology
Clinical and MRI Changes May Influence Prognosis of Patients With CIS
MDedge Neurology
Alemtuzumab, two-course infusion, approved for relapsing MS
MDedge Neurology
Changing Therapies May Benefit Patients With Active MS
MDedge Neurology
Bright Spotty Lesions May Indicate Neuromyelitis Optica Spectrum Disorder
MDedge Neurology
Patient developed PML after taking Tecfidera
MDedge Neurology
FDA issues new pregnancy/lactation drug label standards
MDedge Neurology
Rx for specialists: Know how ACA affects patients’ ability to pay for meds
MDedge Neurology
Risk Stratification Can Guide the Choice of MS Treatment
MDedge Neurology

Related Articles